← Leaderboards
Jonathan Kyle Pokorski
Scripps Research Institute, The
$2,075,618
Attributed
$3,135,142
Total exposure
6
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $634.7K · FY2007–25$1M$750K$500K$250K$0
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$3,135,142 · 6
By mechanism
R01$1,254,030 · 1
R21$865,019 · 2
R00$715,991 · 1
K99$177,485 · 1
F32$122,617 · 1
Top collaborators
- Nicole Franziska Steinmetz6 shared
Most similar at Scripps Research Institute, The
Same institution · by research overlap
- Nicole Franziska Steinmetz$15,228,645
- Shane P Crotty$52,208,511
- Robert F Garry$57,098,933
- Charles W Hespen$308,174
- M.g. Finn$8,667,877
Others in their field
Top investigators on “Site”
- Lawrence Corey · Fred Hutchinson Cancer Center$727,416,881
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Jeffrey P Krischer · University Of South Florida$630,131,001
- David Divins · Consortium For Ocean Leadership, Inc$609,772,544
- Bambra Strokes · Ppd Development Lp$526,656,217
- Tracy L Nolen · Research Triangle Institute$474,487,152
Research focus
SiteVirus-Like ParticleProteinsTechnologyPolymersImplantMouse ModelEnvironmentLeadFutureImmunotherapyImmune ResponseStimulusPharmaceutical PreparationsBaseHydrogelsBacteriophagesDirected EvolutionPeptidesNanoscaleBinding (Molecular Function)InterestParticlePhage Display
Grant awards (14)
CPMV-Polymer Devices to Enhance the Outcomes of Intratumoral Immunotherapy$634,736
R01 · FY2025 · CA
CPMV-Polymer Devices to Enhance the Outcomes of Intratumoral Immunotherapy$619,294
R01 · FY2024 · CA
mRNA COVID-19 Vaccines Delivered with Plant Virus/Polymer Devices$197,500
R21 · FY2022 · AI
mRNA COVID-19 Vaccines Delivered with Plant Virus/Polymer Devices$237,000
R21 · FY2021 · AI
Protein/Polymer Devices for Slow-Release of Immunotherapies to Treat Ovarian Cancer$235,500
R21 · FY2018 · EB · contact PI
Protein/Polymer Devices for Slow-Release of Immunotherapies to Treat Ovarian Cancer$195,019
R21 · FY2017 · EB · contact PI
Development of Protein-Displaying Peptide Hydrogels for Tissue Engineering$235,265
R00 · FY2014 · EB · contact PI
Development of Protein-Displaying Peptide Hydrogels for Tissue Engineering$232,017
R00 · FY2013 · EB · contact PI
Development of Protein-Displaying Peptide Hydrogels for Tissue Engineering$248,709
R00 · FY2012 · EB · contact PI
Development of Protein-Displaying Peptide Hydrogels for Tissue Engineering$89,735
K99 · FY2011 · EB · contact PI
Development of Protein-Displaying Peptide Hydrogels for Tissue Engineering$87,750
K99 · FY2010 · EB · contact PI
Molecular Evoluation of Virus based Hydrogels for Cancer Therapy$30,945
F32 · FY2009 · CA · contact PI
Molecular Evoluation of Virus based Hydrogels for Cancer Therapy$46,826
F32 · FY2008 · CA · contact PI
Molecular Evoluation of Virus based Hydrogels for Cancer Therapy$44,846
F32 · FY2007 · CA · contact PI